BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: D'Amato M, Iengo G, Massa N, Carlomagno C. Dihydropyrimidine dehydrogenase polymorphisms in patients with gastrointestinal malignancies and their impact on fluoropyrimidine tolerability: Experience from a single Italian institution. World J Gastrointest Oncol 2025; 17(1): 96822 [PMID: 39817118 DOI: 10.4251/wjgo.v17.i1.96822]
URL: https://www.wjgnet.com/1948-5204/full/v17/i1/96822.htm
Number Citing Articles
1
Arunkumar Krishnan. Optimizing fluoropyrimidine therapy through dihydropyrimidine dehydrogenase polymorphism testingWorld Journal of Gastrointestinal Oncology 2025; 17(5): 101320 doi: 10.4251/wjgo.v17.i5.101320